ORDER GRANTING IN PART AND DENYING IN PART DEFENDANT’S MOTION TO DISMISS (Doc. 10)
This civil action is currently before the Court on Defendant’s motion to dismiss (Doc. 10) and the parties’ responsive memoranda (Docs. 15,17).
I. FACTUAL BACKGROUND AS ALLEGED BY PLAINTIFF
This action arises out of alleged misrepresentations made by Defendant in its marketing and sale of a product known as “Align.” Align is a daily food supplement, which Procter & Gamble claims is made of a special formulation of “probiotic” bacteria that builds and maintains a healthy digestive system. P & G states on the product label and in its advertisements that these digestive benefits are clinically and scientifically proven.
Plaintiff alleges that these claims are false and misleading and therefore asserts claims for violation of the Consumers Legal Remedies Act (“CLRA”) (California Civil Code Section 1750, et seq.) and the Unfair Competition Law (“UCL”) (Bus. & Prof.Code Section 17200, et seq.), and breach of express warranty created by P & Gs advertising.
P & G, through a broad based campaign, advertises that Align contains a “Unique Patented Probiotic” that it calls “Bifantis.” (Doc. 9 at ¶ 1). On the Align package, P & G promises that Align will help:
*Build and maintain a healthy digestive system
*Restore your natural digestive balance
^Protect against occasional digestive upsets
(Id. at ¶ 2).
P & G also advertises that Align’s digestive benefits are “clinically proven” and
P & G’s claims are made through a broad based advertising campaign. P & G prominently and conspicuously makes these claims on every Align package, and emphasizes and repeats them through a variety of advertising media including television commercials, point of sale displays, and the Internet. (Id. at ¶ 4).
Plaintiff alleges that the Align label makes claims that are false and misleading. For example, P & G’s own “clinical trial” concluded that there were no statistically significant differences between the control group and the group ingesting the “Bifantis” bacteria, B. Infantis. (Id. at ¶ 36). As to the “Clinical Data Publications,” neither provides proof (clinical or otherwise) of the Align claims. Both studies analyzed patients with irritable bowel syndrome, and not Align’s target audience, the general population. (Id. at ¶ 37). A 2006 study tested endpoints irrelevant to P & G’s advertised claims and tested amounts of the bacteria materially different from the amount in a serving of Align (which the authors stressed was important to the study findings). (Id.) A 2005 study found that those persons receiving the Align bacteria did not experience any improvement in the bowel movement markers. (Id.; see also ¶¶38, 39) (allegations concerning “preclinical data publications” and “review articles” identified by P & G as purported substantiation for its Align claims).
Plaintiff alleges that Align is nothing but sugar-filled capsules injected with a small amount of unremarkable bacteria. Nonetheless, customers pay $30 for a 28-count package. (Id. at ¶ 6). Plaintiff read the claims on the Align label, believed they were true, and purchased Align in reliance on P & G’s advertised claims, expecting that he was paying for a product that had proven digestive health benefits. (Id. at ¶10).
II. STANDARD OF REVIEW
Defendant moves the Court for an order dismissing the amended complaint for lack of subject matter jurisdiction and for failure to state a claim upon which relief may be granted.
A. Fed.R.Civ.P. 12(b)(1)
Federal Rule of Civil Procedure 12(b)(1) provides that an action maybe dismissed for lack of subject matter jurisdiction. Under the Federal Rules, “[p]laintiffs have the burden of proving jurisdiction in order to survive a Rule 12(b)(1) motion.”
Weaver v. Univ. of Cincinnati,
B. Fed.R.Civ.P. 12(b)(6)
A motion to dismiss pursuant to Rule 12(b)(6) operates to test the sufficiency of the complaint.
The first step in testing the sufficiency of the complaint is to identify any conclusory allegations.
Ashcroft v. Iqbal,
After assuming the veracity of all well-pleaded factual allegations, the second step is for the court to determine whether the complaint pleads “a claim to relief that is plausible on its face.”
Iqbal,
III. ANALYSIS
A. Lack of Substantiation
Defendant argues that Plaintiff fails to meet the plausibility pleading requirement expressed in
Twombly
and
Iqbal.
The Sixth Circuit has held that courts “cannot dismiss for factual implausibility ‘even if it [would] strike [ ] a savvy judge that recovery is very remote and unlikely.’ ”
Courie v. Alcoa Wheel & Forged Prods.,
Defendant alleges that Plaintiffs complaint is premised entirely on allegations that P & G’s labeling and advertising claims for Align are not adequately substantiated. (Doc. 9 at ¶¶ 1, 3, 13, 17, 18, 20, 22, 23, 25, 28, 29-41). Defendant maintains that, in a false advertising action, a plaintiff must plead and prove that the advertising statements at issue are false or misleading, not merely that they lack adequate scientific substantiation.
Fraker v. Bayer Corp.,
No. CV F 08-1564,
Defendant alleges that, in a false advertising case, plaintiff must plead and prove that the advertising statements are “false or misleading”
2
— which is exactly what
B. Primary Jurisdiction Doctrine
Alternatively, Defendant argues that Plaintiffs claims should be dismissed under the primary jurisdiction doctrine. Primary jurisdiction is a “prudential doctrine under which courts may, under appropriate circumstances, determine that the initial decisionmaking responsibility should be performed by the relevant agency rather than the courts.”
Syntek Semiconductor Co., Ltd. v. Microchip Tech., Inc.,
Dismissal on primary jurisdiction grounds “does not speak to the jurisdictional power of the federal courts,” but rather “structures the proceedings as a matter of judicial discretion, so as to engender an orderly and sensible coordination of the work of agencies and courts.”
United States v. Bessemer & L.E.R.R.,
Plaintiff claims that the doctrine is not properly invoked in this case because the Court does not need an agency’s expertise to resolve his UCL, CLRA, or warranty claims. The doctrine “is not designed to secure expert advice from agencies every time a court is presented with an issue conceivably within the agency’s ambit” but instead “is to be used only if a claim requires resolution of an issue of first impression, or of a particularly complicated issue that Congress has committed to a regulatory agency.”
Clark v. Time Warner Cable,
Defendant argues that Plaintiff has alleged that the advertising claims for Align lack adequate scientific substantiation, and it is this issue — the substantiation of dietary supplement advertising claims — that falls within the primary jurisdiction of the FDA and FTC. Again, as this Court discussed
supra
at Section III.A, that is not the issue before the Court. Additionally, courts have declined to apply the primary jurisdiction doctrine when the party seeking agency referral does not provide evidence that “the FDA has actually taken any interest in investigating the claims or issues presented here.”
Pom Wonderful v. Ocean Spray Cranberries, Inc.,
Accordingly, the Court finds that the primary jurisdiction doctrine is not applicable in the instant case. 5
C. Article III Standing
Next, Defendant claims that Plaintiff fails to establish Article III standing because there are no factual allegations of either personal injury or economic harm. Article III standing requires that a party demonstrate that it: (1) has suffered an injury in fact that is (a) concrete and particularized and (b) actual or imminent, not conjectural or hypothetical; (2) the injury is fairly traceable to the challenged action of the defendant; and (3) it is likely, as opposed to merely speculative, that the injury will be redressed by a favorable decision.
Fieger v. Michigan Supreme Court,
Plaintiff, as a purchaser of Align, alleges “injury in fact” in the form of economic injury. Plaintiff purchased Align in reliance on P & G’s claims that the product provides defined health benefits, when these advertisements were allegedly false and deceptive. (Doc. 9 at ¶ 10). Accordingly, Plaintiff maintains that its purchase of the product is the economic harm, because it was not provided as advertised. (Id.)
There is a considerable body of case law that holds that economic injury confers Article III standing.
Linton v. Comm’n of Health & Env’t,
Accordingly, this Court finds that Plaintiff has alleged a sufficient economic injury to confer standing.
Defendant also claims that Plaintiff lacks standing to seek injunctive relief,
7
because he does not and cannot allege a threat of future injury. (Doc. 15 at 15).
See, e.g., Cattie v. Wal-Mart Stores, Inc.,
Plaintiff argues that injunctive relief is the primary form of relief provided by California’s consumer protection statutes and should therefore survive the motion to dismiss.
9
The amended com
While this Court grapples with this analysis based on the express language of the California statute, the case law appears clear on its face, and Plaintiff fails to produce any authority to the contrary. 11 Accordingly, the Court finds that Plaintiff lacks standing to seek injunctive relief.
D. Statutory Standing
In addition to Article III standing, when stating a claim for violation of a statute, a plaintiff must plead that the statute in question also grants plaintiff the right to sue. Just because a plaintiff satisfies Article III jurisdiction, does not mean that he has statutory standing.
Laster v. T-Mobile USA, Inc.,
No. 05cv1167,
1. UCL Standing
The Unfair Competition Law (“UCL”) prohibits “any unlawful, unfair or fraudulent business act or practice and unfair, deceptive, untrue or misleading advertising.” Cal. Bus.
&
Prof.Code § 17200. “Any violation of the false advertising law” necessarily violates the UCL.
Williams v. Gerber Prod. Co.,
“To satisfy the narrower standing requirements imposed by Proposition 64, a party must now (1) establish a loss or deprivation of money or property sufficient to qualify as injury in fact, i.e., economic injury, and (2) show that the economic injury was the result of, i.e., caused by, the
a. Lost Money
“[Pjlaintiffs who can truthfully allege they were deceived by a product’s label into spending money to purchase the product, and would not have purchased it otherwise, have ‘lost money or property within the meaning of Proposition 64 and have standing to sue.”
Kwikset,
If a party has alleged or proven a personal, individualized loss of money or property in any nontrivial amount, he or she has also alleged or proven injury in fact. Because the lost money or property requirement is more difficult to satisfy than that of injury in fact, for courts to first consider whether lost money or property has been sufficiently alleged or proven will often make sense. If it has not been, standing is absent and the inquiry is complete. If it has been, the same allegations or proof that suffice to establish economic injury will generally show injury in fact as well (ibid.), and thus it will again often be the case that no further inquiry is needed.
Id.,
Defendant argues that Plaintiffs payment of money is not “lost money” if he received the “benefit of the bargain,”
ie.,
he got what he paid for. (Doc. 15 at 16). However, the “benefit of the bargain” reasoning has been criticized and rejected by other courts in determining UCL standing.
See, e.g., Troyk v. Farmers Group, Inc.,
Accordingly, Plaintiff has alleged sufficient facts to establish a loss of money,
b. Reliance
To plead reliance, plaintiff must allege a causal connection between her exposure to the false claims and her purchase of the products.
Laster v. T-Mobile USA, Inc.,
Plaintiff alleges that he read and relied on the statement on the Align label prior to his purchase.
13
(Doc. 9 at ¶ 10). Plaintiff maintains that these allegations are sufficient to, establish causal connection between reading the product label and purchasing the product in reliance on the statements made thereon. Defendant contends that these allegations are insufficient because Plaintiff must identify the “specific representations on the Align label” upon which he relied. (Doc. 17 at 10). Defendant argues that only where the “plaintiff alleges exposure to a
long-term advertising campaign,
the plaintiff is not required to plead with an unrealistic degree of specificity that the plaintiff relied on particular advertisements or statements.”
14
Tobacco II,
Plaintiff argues that individualized reliance on specific misrepresentations is not required to satisfy the reliance requirement. For example, in
Morey,
plaintiff alleged that she “was exposed to and saw NextFood’s claims by reading the product label, purchased GoodBelly products in reliance on these claims, and suffered injury in fact and lost money as result of the unfair competition.”
Based on the case law, it is unclear whether Plaintiff is required to plead reliance with specificity. Moreover, even if the Court finds that pleading with specificity is required — Plaintiff having attached the actual label upon which he relied, appears to meet such a standard. Given that the holding in
Morey
is most recent (June 7, 2010), and alleges identical violations (CLRA, UCL, and breach of an express warranty), the Court finds that Plaintiff
c. Advertising Campaign
Next, Defendant contends that if Plaintiff in fact has standing to challenge P & G’s alleged false advertising, such claim is limited to the advertisements made on the product’s label and does not extend to other forms of advertisements. (Doc. 15 at 17). This same argument was recently alleged in
Morey,
where the court held that at the pleading stage, a plaintiff is “not required to plead with an unrealistic degree of specificity that the plaintiff relied on particular advertisements or statements.”
Morey,
Applying Defendant’s reasoning, every class action would need a representative for every type of advertisement— radio, television, labeling, internet, newspaper, etc. In the instant case, Plaintiff alleged that all of the advertisements for Align carried the same message and misrepresentations.
17
(Doc. 9 at ¶¶ 4-5).
See, e.g., Fitzpatrick v. General Mills, Inc.,
Defendant argues that given the fact that the product packaging for Align has changed over time, Plaintiffs identification of the specific advertising statements on which he relied is essential. For example, in
Johns v. Bayer Corp,
No. 09CV1935,
2. CLRA Standing
The Consumers Legal Remedies Act (“CLRA”) contains similar language establishing a standing requirement. California requires a plaintiff suing under the CLRA for misrepresentations in connection with a sale to plead and prove he relied on a material misrepresentation.
Caro v. Procter & Gamble Co.,
E. Fed.R.Civ.P. 8 and 9
Next, Defendant claims that Plaintiffs conclusory allegations fail to state a plausible claim for relief pursuant to Rule 8 or the particularity requirements of Rule 9(b).
Rule 8 provides that in order to state a claim for relief in a pleading it must contain “a short and plain statement of the grounds for the court’s jurisdiction” and “a short and plain statement of the claim showing that the pleader is entitled to relief.” Fed.R.Civ.P. 8(a)(1) & (2). To survive a motion to dismiss the plaintiff must allege “only enough facts to state a claim to relief that is plausible on its face.”
Twombly,
Federal Rule of Civil Procedure 9(b)’s heightened-pleading standards apply to claims for violation of the UCL or CLRA that are grounded in fraud.
18
Vess
v. Ciba-Geigy Corp. USA,
Plaintiff maintains that the amended complaint complies with Rule
Accordingly, as required pursuant to Rule 9(b), Plaintiff alleged in the amended complaint when he saw, read, and relied upon Align’s material, and what information was false and misleading. Although Plaintiffs allegations could have been more detailed, they do meet Rule 9(b)’s pleading requirement. Additional details are the appropriate subject of discovery, and this is not a case where Defendant will be forced to do discovery in the absence of a plausible claim for relief.
F. Failure to State a Claim under UCL
The UCL
20
proscribes unlawful business practices by borrowing violations of other laws and making them independently actionable under the UCL.
21
Cel-Tech Commc’ns, Inc. v. Los Angeles Cellular Tel. Co.,
Plaintiff claims that Defendant has violated Cal. Civil Code §§ 1572 (actual fraud), 1573 (constructive fraud), 1709 (fraudulent deceit), 1710 (what constituted deceit),
22
1711 (deceit upon the public), 1770 (unlawful practices); Business & Professions Code § 17200 et seq. (misleading advertising);
23
and Cal. Health
&
Safety
First, Defendant claims that a violation of the Federal Food, Drug and Cosmetic Act (“FDCA”) (21 U.S.C. § 343) cannot serve as predicated under the UCL unlawful prong since the FDCA expressly precludes private enforcement.
Perez v. Nidek Co.,
Next, Defendant argues that Plaintiffs predicate claims for fraud and deceit (Cal. Civ.Code §§ 1572, 1573, 1709, 1710, and 1711) should be dismissed because they are not plead with particularity.
Tietsworth v. Sears, Roebuck & Co.,
No. 5:09cv00288,
G. Monetary Damages Under CLRA
In order to bring a claim for monetary damages under the CLRA, a plaintiff must comply with the notice requirement of Section 1782. California Civil Code § 1782(a) requires that “[t]hirty days or more prior to the commencement of an action for damages pursuant to [the CLRA], the consumer shall ...: (1) [notify the person alleged to have employed or committed methods, acts, or practices declared unlawful ... of the particular alleged violationsf; and] (2) [d]emand that the person correct, repair, replace or otherwise rectify the goods or services alleged to be in violation.” The notice must be in writing and sent by certified or registered mail, return receipt requested, to the place where the transaction occurred or to the person’s principal place of business in California.
Von Grabe v. Sprint PCS,
In his first complaint, Plaintiff sought “restitution and disgorgement.” (Doc. 1, Prayer for Relief at C). Plaintiff did not comply with the CLRA notice requirements, as he alleges that notice was not required because he did not seek “damages” under the CLRA in the original complaint.
See, e.g., In Re Mattel, Inc.,
Conversely, Defendant alleges that Plaintiffs claims for monetary damages under the CLRA should be dismissed with prejudice because he was required to serve his CLRA notice letter at the time he filed his original complaint, because the CLRA notice requirement also applies to restitution and disgorgement. The court in Laster held that:
“Section 1780, which list[s] the available remedies for violations of the section, includes “actual damages,” injunctive relief, and restitution of property. To interpret Section 1782’s notice requirement for “damages” to be limited to “actual damages” would render the word “actual” in Section 1780 redundant. In addition, if the Legislature intended Section 1782’s reference to “damages” to include only “actual damages” it is unclear why it would specifically exempt only injunctive relief from the notice requirement in Section 1782(d). Accordingly, the Court finds that the notice requirement applies to monetary damages, regardless of whether such damages are calculated based upon the unjust enrichment of Defendant or the Plaintiffs’ loss. Plaintiffs’ restitution claim under CLRA is therefore dismissed with prejudice.”
Laster v. T-Mobile USA, Inc.,
Laster
(August 11, 2008) was decided after both
Kennedy
(August 7, 2007) and
Utility Consumer’s Action Network
(April 25, 2008), and, therefore, Defendant asks that this Court adopt its reasoning.
30
However, this Court finds the reasoning in
Laster
to be misplaced as explained in
Kennedy.
“[A]s to requests for other equitable relief, such as restitution ... the CLRA does not specify any presuit notice requirement.”
Kennedy v. Natural Balance Pet Foods, Inc.,
No. 07-cv1082,
H. Breach of Express Warranty
Defendant claims that Plaintiff fails to properly plead the elements of a claim for breach of express warranty, and, instead, only conclusorily alleged the existence of a warranty. Under California law, to prevail on a breach of express warranty claim a plaintiff must prove: (1) the seller’s statement constitutes an affirmation of fact or promise, or a description of the goods; (2) the statement was part of the basis of the bargain; and (3) the warranty was breached.
Weinstat v. Dentsply Intern., Inc.,
Specifically, Defendant argues that Plaintiff has failed to identify the express affirmations of fact in the advertisements that constitute an alleged warranty and because Plaintiff failed to do so, his express warranty claim fails on this basis alone. (Doc. 10 at 24). Moreover, Defendant maintains that Plaintiff has not adequately alleged facts demonstrating how any alleged warranty was breached, that he relied on any alleged warranty, or that he was injured as a result of any such breach. (Id.)
In the amended complaint, Plaintiff alleges that
[he] and each member of the Class, formed a contract with defendants at the time plaintiff and the other members of the Class purchased Align. The terms of that contract include the promises and affirmations of fact made by Procter & gamble on its Align product labels and through other marketing campaigns, as described above. This advertising, including labeling, constitutes express warranties, became part of the basis of the bargain, and is part of a standardized contract between plaintiff and the members of the Class on the one hand, and Procter & Gamble on the other.
(Doc. 9 at ¶ 77).
Contrary to Defendant’s argument otherwise, the Court finds that Plaintiffs amended complaint clearly alleges what benefits were expected.
31
(Doc. 9 at ¶¶ 19-28). Plaintiff has identified the particular advertisement upon which he relied
(Id.
at ¶ 21), and he has described with the requisite specificity the content of that particular advertisement. Moreover, the Court has already concluded that Plaintiff has adequately pled reliance, injury, and causation.
(See
Sections II.D.l.a; b,
supra).
Although Plaintiff did not directly quote the “exact terms” of Defendant’s warranty, the Court finds that Plaintiffs allegations are sufficient. Accepting all material allegations in the complaint as true while construing them in the light most favorable to Plaintiff, the amended
I. Class Action
Finally, Defendant argues that Plaintiff cannot pursue California state law claims under the UCL and CLRA on behalf of a proposed class that includes out-of-state residents. California statutory remedies may be invoked by out-of-state parties, but only when they are harmed by conduct occurring in California.
Diamond Multimedia Sys. v. Superior Court,
Despite the sense that Defendant’s argument appears meritorious on its face, the Court has not yet been apprised of the members of the prospective class, and it is therefore premature to rule upon a factual issue that is not properly before the Court.
See, e.g., Lockwood,
IV. CONCLUSION
Accordingly, for the reasons stated herein, Defendant’s motion to dismiss (Doc. 10) is GRANTED IN PART and DENIED IN PART. Specifically, Defendant’s motion is GRANTED with respect to Plaintiffs claim for injunctive relief and DENIED on all other grounds.
IT IS SO ORDERED.
Notes
. In
Fraker,
the FTC issued a cease and desist order directing Bayer to halt advertising until it provided substantiation for its claims. Bayer violated the order, the government sued, and the case settled, resulting in a consent decree.
Id.
at *1-2,
.
Nat’l Council Against Health Fraud, Inc. v. King Bio Pharm., Inc.,
. The Food and Drug Administration ("FDA”) and the Federal Trade Commission ("FTC”) share jurisdiction over the regulation of dietary supplements. Under the Food, Drug, and Cosmetic Act, as amended by the Dietary Supplement Health and Education Act, the FDA has primary responsibility for the labeling of dietary supplements. 21 U.S.C. § 343(r)(6).
.
See also, Chacanaca v. The Quaker Oats Co.,
. Defendant cites just one product labeling case involving primary jurisdiction. That case concerned "whether Redline and/or its ingredients should be approved as safe ..., these issues are best suited for the FDA.”
Aaronson v. Vital Pharms., Inc.,
No. 09-cv-1333,
.
See, e.g., Mathison v. Linnborn,
No. SA CV08-0369,
. Doc. 9 at ¶ 59 ("[Pjlaintiff and the Class seek a Court order enjoining the above-described wrongful acts and practices.”); ¶ 75 ("Plaintiff seeks an order requiring Procter & Gamble to immediately cease such acts ... and requiring [it] to engage in a corrective advertising campaign.”), Prayer for Relief at ¶ D (seeking an order "enjoining defendants from continuing the unlawful practices as set forth herein.”).
. The Court notes that in Cattie, the plaintiff did not plead reliance on the false advertisements at issue. Id. at 946. After ruling on reliance, which was dispositive of all claims, the court raised the issue of plaintiff’s separate standing to pursue injunctive relief sua sponte. The court did not dismiss the claim for injunctive relief, but permitted the parties to file points and authorities on the issue. Id. at 951-952. The case was dismissed before briefing and the standing issue was never decided by the court.
. See Tobacco II,
.
Compare, Wilner v. Sunset Life Ins. Co.,
. "A plaintiff might have standing to pursue a request for an injunction under California’s UCL in California state court but not necessarily have Article III standing to pursue them in federal court.”
Chavez v. Nestle USA,
No. 09-9192,
.
Morey v. NextFoods Inc.,
No. 10cv761,
. See also Doc. 9 at Ex. 1, which, reflects 10 photographs of Align packaging/labeling with the language upon which Plaintiff relied in making his purchase.
. "[OJnly the named Plaintiff in a class action suit must show
actual reliance
on deceptive advertising.”
Id.
at 306,
. However, in Brownfield, plaintiffs did not allege any facts that they viewed either of the ads at issue prior to purchasing the product or that they purchased in reliance on the challenged aspects of the ads and were injured as a result.
. Plaintiff also cites
Morgan v. AT & T Wireless Serv. Inc.,
. "Procter & Gamble conveyed and continues to convey its deceptive claims about Align through a variety of media, including the Internet, in-store sampling, point of sale displays, and on the Align probiotic supplement’s labels and labeling. These representations appear prominently and conspicuously on every Align container. Through this advertising, Procter & Gamble has conveyed one message: Align, with its probiotic bacteria cultures, provides clinically proven digestive health benefits to the general public. Attached as Exhibit 1 is a collection of some of the advertisements and labeling containing the false and deceptive advertising claim.” (Doc. 9 at ¶¶ 4, 5).
. Under California law, the "indispensable elements of a fraud claim include a false representation, knowledge of its falsity, intent to defraud, justifiable reliance, and damages.”
Moore v. Brewster, 96
F.3d 1240, 1245 (9th Cir.1996) (citing
Bank of the West v. Valley Nat’l Bank of Arizona,
. Defendant argues that Plaintiff must identify when and where he saw the allegedly false and misleading statements on the product label, and when and where he purchased the product.
In re Hydroxycut Mktg. & Sales Practices Litig.,
No. 09MD2087,
. The purposes of the UCL are "to safeguard the public against the creation of perpetuation of monopolies and to foster and encourage competition, by prohibiting unfair, dishonest, deceptive, destructive, fraudulent and discriminatory practices by which fair and honest competition is destroyed or prevents.” Cal. Bus. & Prof.Code § 17001.
. "A business practice is unfair within the meaning of the UCL if it violates established public policy or if it is immoral, unethical, oppressive or unscrupulous and causes injury to consumers which outweighs its benefits.”
McKell v. Washington Mut., Inc.,
. This is a definition section for Cal. Civ. Code § 1709, and it is therefore inapplicable.
. "Virtually any state, federal or local [common] law can serve as the predicate for an action” under section 17200.
Podolsky v.
. This is a definition section for 21 U.S.C. § 301 et seq., and it is therefore inapplicable.
. “It would be impossible to draft in advance detailed plans and specifications of all acts and conduct to be prohibited, since unfair or fraudulent business practices may run the gamut of human ingenuity and chicanery.”
People ex rel. Mosk v. Nat’l Research Co. of Cal.,
. "Section 337(a) of the FDCA provides that all proceedings for the enforcement, or to restrain violations of [the Act] shall be by and in the name of the United States.” Courts have interpreted section 337(a) as prohibiting private rights of action under the FDCA and have dismissed state law claims that seek to enforce the FDCA or its regulations. Id.
. With the exception of Cal. Civ.Code § 1710, which, as explained supra, is not a substantive claim, and it is therefore ordered stricken from the amended complaint.
. Plaintiff claims that Defendant’s systematic breach of its warranties is a predicate violation for purposes of the UCL’s unlawful prong.
.
See also Stickrath v. Globalstar, Inc.,
. "A district court's opinion is not binding on other district courts.”
Krangel v. Lester Crown,
. For example, ''[bjuild and maintain a health [sic] digestive system; Restore your natural digestive balance; [and] Protect against occasional digestive upsets.” (Doc. 9 at ¶ 19).
